Trademark: 97289827
Word
KEXFIBRY
Status
Pending
Status Code
731
Status Date
Wednesday, January 24, 2024
Serial Number
97289827
Mark Type
4000
Filing Date
Tuesday, March 1, 2022
Published for Opposition
Tuesday, January 17, 2023

Trademark Owner History
Gilead Sciences Ireland UC - Owner At Publication

Classifications
5 Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders

Trademark Events
Jan 26, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 24, 2024
Sou Extension 2 Granted
Jan 24, 2024
Sou Extension 2 Filed
Jan 24, 2024
Sou Teas Extension Received
Aug 5, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 3, 2023
Sou Extension 1 Granted
Aug 3, 2023
Sou Extension 1 Filed
Aug 3, 2023
Sou Teas Extension Received
Mar 14, 2023
Noa E-Mailed - Sou Required From Applicant
Jan 17, 2023
Official Gazette Publication Confirmation E-Mailed
Jan 17, 2023
Published For Opposition
Dec 28, 2022
Notification Of Notice Of Publication E-Mailed
Dec 12, 2022
Approved For Pub - Principal Register
Dec 12, 2022
Assigned To Examiner
Mar 4, 2022
New Application Office Supplied Data Entered
Mar 4, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24